(Q53553184)

15 May 2018

title

Quality of life as a treatment outcome in patients with cystic fibrosis. (English)

1 reference

15 May 2018

0 references

1 reference

Munzenberger PJ

1

1 reference

15 May 2018

Van Wagnen CA

series ordinal

2

1 reference

15 May 2018

Abdulhamid I

series ordinal

3

1 reference

15 May 2018

Walker PC

series ordinal

4

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 April 1999

1 reference

15 May 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Pharmacotherapy

1 reference

15 May 2018

volume

19

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

393-398

1 reference

15 May 2018

Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Effect of rhDNase on lung function and quality of life in adult cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Measurement of quality of well being in a child and adolescent cystic fibrosis population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

The quality of well-being in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

Quality of life in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.6.393.31047

10.1592/PHCO.19.6.393.31047

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018